Viewing Study NCT04084769


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-02-22 @ 3:55 PM
Study NCT ID: NCT04084769
Status: COMPLETED
Last Update Posted: 2025-09-15
First Post: 2019-09-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Meningococcal Immunisation (Healthy Volunteers) View
Keywords: